Latest Catheter ablation Stories
American Heart Association/American College of Cardiology/Heart Rhythm Society GuidelinesStatement Highlights:   * Strict heart rate control in atrial fibrillation patients is not beneficial over lenient control.   * The antiplatelet drug clopidogrel, plus aspirin, might be considered to reduce the risk of major vascular events, including stroke in patients who are poor candidates for the anticoagulant drug warfarin.   * Catheter ablation is useful to maintain...
Utilizing Cardiac Hybrid Operating Room allows for state-of-the-art, collaborative approach to care. NORFOLK, Va., Dec. 2, 2010 /PRNewswire-USNewswire/ -- Sentara Heart Hospital is breaking new ground in cardiac care and treatment. Surgeons and Cardiologists at Sentara Heart Hospital are first to begin enrolling and performing trial cases in the AtriCure DEEP AF feasibility trial. The first procedure in the country was performed in a new, state-of-the-art hybrid operating room at Sentara...
WATERLOO, Belgium, November 22, 2010 /PRNewswire/ -- According to data published last week in Circulation Cardiovascular Quality and Outcomes, patients with a common heart rhythm disorder, called atrial fibrillation, who were treated with catheter ablation using the NaviStar(R)ThermoCool(R) Catheter, reported markedly fewer symptoms and substantially improved quality of life than patients treated with antiarrhythmia drugs at one year. Atrial fibrillation, or AFib as it is more...
University of Leicester researcher in pioneering procedure at Leicester hospitalThe world's first remote heart procedure, using a robotic arm alongside 3-D mapping, is due to take place at Glenfield Hospital in Leicester.It comes six months after Dr Andre Ng carried out the first ever remote catheter ablation procedure using the Amigo Robotic Catheter System.Dr Ng, is senior lecturer at the University of Leicester and consultant cardiologist and electrophysiologist at Glenfield Hospital.On...
By Rachel Champeau, UCLANew study reports on UCLA medical team's experience with new techniquesNew techniques now being used at UCLA allow doctors to more precisely target certain areas of the heart to stop ventricular arrhythmias "” serious abnormal rhythms in the heart's lower chambers "” in high-risk patients.Generally, arrhythmias can be controlled by medications, and sometimes defibrillators. But a potentially life-threatening, recurrent arrhythmia known as a ventricular tachycardia,...
Study highlights: -- A medical procedure (catheter ablation) that uses a heat pulse to destroy malfunctioning heart muscle cells successfully treats a common form of irregular heartbeat, known as atrial fibrillation, in patients younger than 45. -- Compared with older patients, those under 45 suffered fewer major complications and were less likely to later require medication to control their irregular heartbeat. -- Researchers' findings suggest that catheter ablation may be an...
ST. LOUIS, Sept. 8 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. (Nasdaq: STXS) highlighted significant new additions to the body of evidence demonstrating exceptional clinical outcomes achieved with its Niobe® Magnetic Navigation System in ventricular tachycardia (VT) ablation. At the European Cardiology Society Annual Congress in Stockholm last week, the research team led by Dr. Tamas Szili-Torok from the Erasmus Medical Center in Rotterdam presented the first comparative trial in a...
WATERLOO, Belgium, July 8, 2010 /PRNewswire/ -- Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announces that more than 10 patients have now been enrolled in the CLARITY-study ("CLARITY-AF"), comparing the efficacy, safety and efficiency of CARTO(R) 3 System guided radiofrequency ablation using the NAVISTAR(R) THERMOCOOL(R) catheter versus fluoroscopy guided radiofrequency ablation using the Pulmonary Vein Ablation catheter(R) (PVAC(R),...
RALEIGH, N.C., June 23 /PRNewswire/ -- nContact Surgical, Inc. (nContact) reports with interest today the results of a physician-initiated study of the Convergent Procedure that, for the first time, measured the progress of persistent atrial fibrillation (AF) patients at one-year and six-month intervals. Results of the study, which were presented at the 2010 International Society of Minimally Invasive Cardiac Surgeons (ISMICS) meeting in Berlin, Germany, indicated that after one year 80% of...
CLEVELAND, June 14 /PRNewswire-FirstCall/ -- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced that medical technology company Endosense has awarded DATATRAK the first two studies in the EFFICAS study series. The EFFICAS studies are intended to demonstrate that the use of contact force control during cardiac ablation utilizing Endosense's TactiCath® force-sensing catheter...
